BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27823872)

  • 1. Epidemiologic Trends in Loperamide AbuseĀ andĀ Misuse.
    Vakkalanka JP; Charlton NP; Holstege CP
    Ann Emerg Med; 2017 Jan; 69(1):73-78. PubMed ID: 27823872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intentional Misuse and Abuse of Loperamide: A New Look at a Drug with "Low Abuse Potential".
    Borron SW; Watts SH; Tull J; Baeza S; Diebold S; Barrow A
    J Emerg Med; 2017 Jul; 53(1):73-84. PubMed ID: 28501383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loperamide misuse and abuse.
    Miller H; Panahi L; Tapia D; Tran A; Bowman JD
    J Am Pharm Assoc (2003); 2017; 57(2S):S45-S50. PubMed ID: 28189538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loperamide Trends in Abuse and Misuse Over 13 Years: 2002-2015.
    Lasoff DR; Koh CH; Corbett B; Minns AB; Cantrell FL
    Pharmacotherapy; 2017 Feb; 37(2):249-253. PubMed ID: 27995643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loperamide misuse to avoid opioid withdrawal and to achieve a euphoric effect: high doses and high risk.
    Lee VR; Vera A; Alexander A; Ruck B; Nelson LS; Wax P; Campleman S; Brent J; Calello DP
    Clin Toxicol (Phila); 2019 Mar; 57(3):175-180. PubMed ID: 30585509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse event detection using the FDA post-marketing drug safety surveillance system: Cardiotoxicity associated with loperamide abuse and misuse.
    Swank KA; Wu E; Kortepeter C; McAninch J; Levin RL
    J Am Pharm Assoc (2003); 2017; 57(2S):S63-S67. PubMed ID: 28073687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loperamide cases reported to United States poison centers, 2010-2022.
    Patel A; Rine NI; Spiller HA; Hays H; Badeti J; Zhu M; Ding K; Smith GA
    Inj Epidemiol; 2023 Nov; 10(1):61. PubMed ID: 38001549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notes from the Field: Cardiac Dysrhythmias After Loperamide Abuse - New York, 2008-2016.
    Eggleston W; Marraffa JM; Stork CM; Mercurio-Zappala M; Su MK; Wightman RS; Cummings KR; Schier JG
    MMWR Morb Mortal Wkly Rep; 2016 Nov; 65(45):1276-1277. PubMed ID: 27855148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in intentional abuse and misuse ingestions in school-aged children and adolescents reported to US poison centers from 2000-2020.
    Hughes AR; Grusing S; Lin A; Hendrickson RG; Sheridan DC; Marshall R; Horowitz BZ
    Clin Toxicol (Phila); 2023 Jan; 61(1):64-71. PubMed ID: 36469528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in gabapentin and baclofen exposures reported to U.S. poison centers.
    Reynolds K; Kaufman R; Korenoski A; Fennimore L; Shulman J; Lynch M
    Clin Toxicol (Phila); 2020 Jul; 58(7):763-772. PubMed ID: 31786961
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of lisdexamfetamine and dextroamphetamine exposures reported to U.S. poison centers.
    Kaland ME; Klein-Schwartz W
    Clin Toxicol (Phila); 2015 Jun; 53(5):477-85. PubMed ID: 25832473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of quetiapine abuse and misuse reported to poison centers.
    Klein-Schwartz W; Schwartz EK; Anderson BD
    J Addict Med; 2014; 8(3):195-8. PubMed ID: 24662370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abuse and Intentional Misuse of Promethazine Reported to US Poison Centers: 2002 to 2012.
    Tsay ME; Procopio G; Anderson BD; Klein-Schwartz W
    J Addict Med; 2015; 9(3):233-7. PubMed ID: 25822213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loperamide as a Potential Drug of Abuse and Misuse: Fatal Overdoses at the Medical University of South Carolina.
    Powell JW; Presnell SE
    J Forensic Sci; 2019 Nov; 64(6):1726-1730. PubMed ID: 31219627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abuse, misuse, and suicidal substance use by children on school property.
    Vakkalanka JP; King JD; Holstege CP
    Clin Toxicol (Phila); 2015 Nov; 53(9):901-7. PubMed ID: 26503790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Child and adolescent benzodiazepine exposure and overdose in the United States: 16 years of poison center data.
    Friedrich JM; Sun C; Geng X; Calello DP; Gillam M; Medeiros KL; Smith M; Ruck B; Mazer-Amirshahi M
    Clin Toxicol (Phila); 2020 Jul; 58(7):725-731. PubMed ID: 31612741
    [No Abstract]   [Full Text] [Related]  

  • 17. Not your regular high: cardiac dysrhythmias caused by loperamide.
    Wightman RS; Hoffman RS; Howland MA; Rice B; Biary R; Lugassy D
    Clin Toxicol (Phila); 2016 Jun; 54(5):454-8. PubMed ID: 27022002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Review: Loperamide Toxicity.
    Wu PE; Juurlink DN
    Ann Emerg Med; 2017 Aug; 70(2):245-252. PubMed ID: 28506439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in dextromethorphan cough and cold products: 2000-2015 National Poison Data System intentional abuse exposure calls.
    Karami S; Major JM; Calderon S; McAninch JK
    Clin Toxicol (Phila); 2018 Jul; 56(7):656-663. PubMed ID: 29260900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there such a thing as a 'lope' dope? Analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports.
    Schifano F; Chiappini S
    PLoS One; 2018; 13(10):e0204443. PubMed ID: 30286103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.